Targeting mitochondria as therapeutic strategy for metabolic disorders

Daniela Sorriento, Antonietta Valeria Pascale, Rosa Finelli, Anna Lisa Carillo, Roberto Annunziata, Bruno Trimarco, Guido Iaccarino

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. Finally, novel mechanisms of regulation of mitochondrial function are discussed, which open new scenarios for mitochondria targeting.

Original languageEnglish
Article number604685
JournalTheScientificWorldJournal
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Mitochondria
mitochondrion
targeting
cancer
diabetes
Oxidative Phosphorylation
cardiovascular disease
Medical problems
Mitochondrial DNA
Metabolism
defect
mutation
Neoplasms
Cardiovascular Diseases
Therapeutics
metabolism
Defects
Mutation
Molecules

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Medicine(all)

Cite this

Sorriento, D., Pascale, A. V., Finelli, R., Carillo, A. L., Annunziata, R., Trimarco, B., & Iaccarino, G. (2014). Targeting mitochondria as therapeutic strategy for metabolic disorders. TheScientificWorldJournal, 2014, [604685]. https://doi.org/10.1155/2014/604685

Targeting mitochondria as therapeutic strategy for metabolic disorders. / Sorriento, Daniela; Pascale, Antonietta Valeria; Finelli, Rosa; Carillo, Anna Lisa; Annunziata, Roberto; Trimarco, Bruno; Iaccarino, Guido.

In: TheScientificWorldJournal, Vol. 2014, 604685, 2014.

Research output: Contribution to journalArticle

Sorriento, D, Pascale, AV, Finelli, R, Carillo, AL, Annunziata, R, Trimarco, B & Iaccarino, G 2014, 'Targeting mitochondria as therapeutic strategy for metabolic disorders', TheScientificWorldJournal, vol. 2014, 604685. https://doi.org/10.1155/2014/604685
Sorriento D, Pascale AV, Finelli R, Carillo AL, Annunziata R, Trimarco B et al. Targeting mitochondria as therapeutic strategy for metabolic disorders. TheScientificWorldJournal. 2014;2014. 604685. https://doi.org/10.1155/2014/604685
Sorriento, Daniela ; Pascale, Antonietta Valeria ; Finelli, Rosa ; Carillo, Anna Lisa ; Annunziata, Roberto ; Trimarco, Bruno ; Iaccarino, Guido. / Targeting mitochondria as therapeutic strategy for metabolic disorders. In: TheScientificWorldJournal. 2014 ; Vol. 2014.
@article{de5f7703686e4111b67dabed20c1cfea,
title = "Targeting mitochondria as therapeutic strategy for metabolic disorders",
abstract = "Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. Finally, novel mechanisms of regulation of mitochondrial function are discussed, which open new scenarios for mitochondria targeting.",
author = "Daniela Sorriento and Pascale, {Antonietta Valeria} and Rosa Finelli and Carillo, {Anna Lisa} and Roberto Annunziata and Bruno Trimarco and Guido Iaccarino",
year = "2014",
doi = "10.1155/2014/604685",
language = "English",
volume = "2014",
journal = "The Scientific World Journal",
issn = "2356-6140",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Targeting mitochondria as therapeutic strategy for metabolic disorders

AU - Sorriento, Daniela

AU - Pascale, Antonietta Valeria

AU - Finelli, Rosa

AU - Carillo, Anna Lisa

AU - Annunziata, Roberto

AU - Trimarco, Bruno

AU - Iaccarino, Guido

PY - 2014

Y1 - 2014

N2 - Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. Finally, novel mechanisms of regulation of mitochondrial function are discussed, which open new scenarios for mitochondria targeting.

AB - Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. Finally, novel mechanisms of regulation of mitochondrial function are discussed, which open new scenarios for mitochondria targeting.

UR - http://www.scopus.com/inward/record.url?scp=84897529482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897529482&partnerID=8YFLogxK

U2 - 10.1155/2014/604685

DO - 10.1155/2014/604685

M3 - Article

C2 - 24757426

AN - SCOPUS:84897529482

VL - 2014

JO - The Scientific World Journal

JF - The Scientific World Journal

SN - 2356-6140

M1 - 604685

ER -